|
2026
|
P/S
|
Ophthalmic surgery devices and instruments for controlled sub-retinal delivery of pharmaceutical,... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cardiovascular, metabolic and renal diseases and... |
|
|
P/S
|
Pharmaceutical preparations for use in neuroscience |
|
|
P/S
|
Pharmaceutical preparations for use in nephropathy. |
|
|
P/S
|
Pharmaceutical preparations for use in nephropathy |
|
|
P/S
|
IC 010: Ophthalmological apparatus and instruments, namely, implantable ocular drug delivery devi... |
|
|
P/S
|
pharmaceutical preparations for use in oncology |
|
2025
|
Invention
|
Method for the reduction of host cell proteins in affinity chromatography.
The current invention... |
|
|
P/S
|
Downloadable computer software for health and medical data analysis and downloadable computer sof... |
|
|
P/S
|
Platform as a service (PAAS) featuring computer software platforms for early detection of cancer;... |
|
|
Invention
|
Connected machine-learning models with joint training for lesion detection.
Embodiments disclose... |
|
|
Invention
|
Density-based immunophenotyping.
Described herein are methods, systems, and programming for dete... |
|
|
Invention
|
Anti-tl1a antibody therapeutic methods.
The present disclosure provides methods and compositions... |
|
|
Invention
|
Three-dimensional molecule generation by denoising voxel grids.
A voxelized representation of an... |
|
|
Invention
|
Three-dimensional molecule generation in latent voxelized space.
A voxelized representation of a... |
|
|
Invention
|
Systems and methods for phasing mutations in tumors.
This application relates generally to analy... |
|
|
Invention
|
Antibody formulations.
Formulations comprising an anti-IL-13 antibody are provided, including ph... |
|
|
Invention
|
Methods for treatment of cd20-positive proliferative disorder with mosunetuzumab and polatuzumab ... |
|
|
Invention
|
Weakly supervised lesion segmentation.
A Generative Adversarial Network (GAN) can be trained, wh... |
|
|
Invention
|
Developing an efficient hybridoma platform for therapeutic antibody discovery.
The instant techn... |
|
|
Invention
|
Treatment of spinal muscular atrophy.
Disclosed herein are methods for treating spinal muscular ... |
|
|
Invention
|
Machine learning enabled longitudinal analysis of positron emission tomography and computed tomog... |
|
|
Invention
|
Biomarkers and methods of treating pd-1 and pd-l1 related conditions.
Provided herein are biomar... |
|
|
Invention
|
Combination therapies for treatment of breast cancer.
Provided are combination therapies compris... |
|
|
P/S
|
Pharmaceutical preparations for use in the treatment of neurological diseases; pharmaceutical pre... |
|
|
Invention
|
Isoform-selective anti-tgf-beta antibodies and methods of use.
The invention provides isoform-se... |
|
|
Invention
|
Systems and methods for interpretable neural networks for genomic analysis. In one embodiment, a ... |
|
|
Invention
|
Methods for treatment of atopic dermatitis with an anti-tl1a antibody. The present disclosure pro... |
|
|
Invention
|
Methods for treatment of metabolic dysfunction-associated steatohepatitis with an anti-tl1a antib... |
|
|
Invention
|
Combination therapy of peptide tyrosine-tyrosine (pyy) analogues and glp-1r agonists. The present... |
|
|
Invention
|
Pharmacophore-based molecule design by learning on voxel grids. A three-dimensional representatio... |
|
|
Invention
|
Compositions and methods of treating lupus nephritis. inter aliainter alia, methods for depleting... |
|
|
Invention
|
Methods of protein production.
A method of reducing glycation of an amino acid in a protein prod... |
|
|
Invention
|
Formulations with reduced oxidation.
The invention provides formulations comprising a protein in... |
|
|
Invention
|
Generative design of small molecules.
Methods for the generative design of small molecules inclu... |
|
|
Invention
|
Methods of treating cancer with an anti-pd-l1 antibody.
The present disclosure relates to method... |
|
|
Invention
|
Tmem175 modulators. Provided herein are TMEM175 modulators having Formula (I) and pharmaceuticall... |
|
|
Invention
|
Unifying foundation model for functional genomics. Machine learning-based methods, systems, and p... |
|
|
Invention
|
Crispr repair in vitro screen (cris) off-target assessment. Disclosed herein are methods to asses... |
|
|
Invention
|
Therapeutic and diagnostic methods for cancer.
The present invention provides therapeutic and di... |
|
|
Invention
|
Expression of fc-containing proteins.
The present invention provides compositions comprising a F... |
|
|
Invention
|
Methods for treating cancer using subcutaneous dosing of mosunetuzumab in combination with polatu... |
|
|
Invention
|
Subcutaneous dosing of mosunetuzumab in combination with polatuzumab vedotin for use in treating ... |
|
|
Invention
|
Inducible crispr/cas systems with high dynamic range and methods of use. Systems, methods, and co... |
|
|
Invention
|
Generative protein design with smoothed energy-based models.
A training set may be generated to ... |
|
|
Invention
|
Methods and systems for decoding gene expression in individual cell types and disease states. Thi... |
|
|
Invention
|
Dosage regimen for reducing cytokine release syndrome (crs) with anti-fcrh5/anti-cd3 bispecific a... |
|
|
Invention
|
Precision medicine for optimal dosage of combined therapies systems and methods of use thereof. T... |
|
|
Invention
|
Magnetic hydrogel particles and methods of use.
The present invention relates to particles compr... |
|
|
Invention
|
Methods of making fucosylated and afucosylated forms of a protein.
The present application relat... |
|
|
Invention
|
Treatment of cancer using combination therapies comprising gdc-6036 and gdc-0077.
Provided herei... |
|
|
Invention
|
Anti-htra1 antibodies and methods of use thereof.
The present invention provides anti-HtrA1 anti... |
|
|
P/S
|
Educational services, namely, providing presentations in the field of oncology products and disea... |
|
|
P/S
|
Pharmaceutical preparations, applied subcutaneously, for use in oncology |
|
|
P/S
|
Pharmaceutical preparations for use in neurological disorders including Alzheimer's |
|
|
P/S
|
Pharmaceutical preparations for use in oncology |
|
|
P/S
|
Pharmaceutical preparations for use in the treatment of neurological conditions including Alzheim... |
|
|
Invention
|
Dosing for treatment with anti-cd20/anti-cd3 bispecific antibodies.
The present invention relate... |
|
|
Invention
|
Compositions and methods for the treatment of immune related diseases.
The present invention rel... |
|
|
Invention
|
Brm targeting compounds and associated methods of use.
The present disclosure relates to bifunct... |
|
|
Invention
|
Anti-klk7 antibodies, anti-klk5 antibodies, multispecific anti-klk5/klk7 antibodies, and methods ... |
|
|
Invention
|
Aza-tetracyclic oxazepine compounds and uses thereof.
Provided herein are aza-tetracyclic oxazep... |
|
|
P/S
|
Ophthalmological apparatus and instruments, namely, implantable ocular drug delivery devices |
|
|
Invention
|
Bispecific antigen-binding molecules and methods of use.
The present invention provides bispecif... |
|
|
Invention
|
Methods of producing two chain proteins in prokaryotic host cells.
Provided herein are methods a... |
|
|
Invention
|
Methods and compositions for classifying and treating bladder cancer.
The invention provides met... |
|
|
P/S
|
Software products for healthcare, monitoring, screening, assessment, diagnosis, and intervention,... |
|
2024
|
P/S
|
Pharmaceutical preparations for use in immunology |
|
|
P/S
|
Pharmaceutical preparations for use in oncology, neurology and immunology |
|
|
P/S
|
Pharmaceutical preparations for use in immunology; Pharmaceutical preparations for the treatment ... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of metabolic diseases and disorders, Pharmaceutical... |
|
|
P/S
|
Pharmaceutical preparations for the prevention and treatment of neurological diseases |
|
|
P/S
|
Pharmaceutical preparations for use in the treatment of neurological conditions including Alzheimer |
|
|
P/S
|
Pharmaceutical preparations for use in the treatment of neurological conditions including Alzheimer. |
|
|
P/S
|
Pharmaceutical preparations for use in ophthalmology |
|
|
P/S
|
Pharmaceutical preparations for use in ophthalmology. |
|
|
P/S
|
Downloadable and recorded computer software for collecting and retaining patient data relating to... |
|
|
P/S
|
Education, namely providing training in the field of oncology Medical services, namely, providing... |
|
|
P/S
|
Ophthalmological apparatus and instruments for ophthalmological surgery Education, namely providi... |
